WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Merck

MerckToday's Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.

www.merck.com

Merck RSS Channel

Filters
List of articles in category Merck
Title Published Date
Merck and Ridgeback's molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world 15 November 2021
Merck discontinues development of SARS-CoV-2/COVID-19 vaccine candidates; continues development of two investigational therapeutic candidates 25 January 2021
Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in immuno-oncology 08 September 2017
Merck launches Biosimilars Clarified, a new online educational resource about biosimilar medicines for patients and the healthcare community 17 October 2016
Merck receives Breakthrough Therapy Designation from FDA and PRIME status from EMA for investigational Ebola Zaire vaccine (V920) 26 July 2016
Merck launches Vivera in Latin America 20 January 2016
Merck Acquires IOmet Pharma and expands immuno-oncology development program 11 January 2016
Merck Establishes Joint Venture with Supera Farma 15 February 2012
Merck Publishes 2010 Global Corporate Responsibility Report 03 October 2011
Merck Statement on GARDASIL® 16 September 2011
Merck and Serum Institute Announce Collaboration 12 August 2011
ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor 01 October 2010
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication SAPHRIS® 09 September 2010
Merck Provides New Funding to Fight HIV/AIDS in Botswana 25 August 2010
Single Treatment with ELONVA® Produced Live Birth Rates Comparable to Daily rFSH Injections 30 June 2010
New SIMPONI (Golimumab) Data Shows Sustained Efficacy in the Treatment of Rheumatoid Arthritis 23 June 2010
Merck Announces Launch of Pioneering Collaborative Cancer Trials Network 04 June 2010
Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology 26 May 2010
Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy 12 May 2010
Merck Announces First-Quarter 2010 Financial Results 05 May 2010
  • Start
  • Prev
  • 1
  • 2
  • Next
  • End

Business & Industry

  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
  • AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
  • Pfizer invests $43 billion to battle cancer

Research & Development

  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer
  • Engineered bacteria find tumors, then alert the authorities
  • First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Merck

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.